|1.||Shimizu, Takao: 12 articles (09/2013 - 03/2002)|
|2.||Ishii, Satoshi: 11 articles (01/2010 - 03/2002)|
|3.||Teixeira, Mauro M: 10 articles (03/2014 - 03/2002)|
|4.||Travers, Jeffrey B: 8 articles (01/2015 - 05/2003)|
|5.||van der Poll, Tom: 6 articles (06/2012 - 08/2003)|
|6.||Pinho, Vanessa: 5 articles (10/2015 - 03/2002)|
|7.||Souza, Danielle G: 5 articles (03/2014 - 06/2003)|
|8.||Florquin, Sandrine: 5 articles (06/2012 - 08/2003)|
|9.||Sahu, Ravi P: 4 articles (01/2015 - 03/2012)|
|10.||Konger, Raymond L: 4 articles (01/2014 - 03/2012)|
11/01/1994 - "However, the efficacy of platelet-activating factor receptor antagonist was significantly greater in patients with Gram-negative sepsis (test for interaction, p = .03). "
01/01/2013 - "Finally, as PAR1 seems to play a singular role in Streptococcus pneumoniae-induced sepsis through a crosstalk between PAR1 and platelet-activating factor receptor, the exact role of PAR1 needs to be investigated in other models of sepsis. "
11/01/1994 - "No differences in mortality rates were found between the placebo and the platelet-activating factor receptor antagonist groups in the absence of Gram-negative sepsis. "
11/01/1994 - "When the Gram-negative sepsis population was stratified by age and these five prognostic factors were controlled for, the relative risk of death of the platelet-activating factor receptor antagonist group was 0.61 (0.34 to 1.08, 95% confidence interval; p = .09). "
11/01/1994 - "In a separate analysis of patients with and without Gram-negative sepsis, the 28-day mortality rate was 57% for the patients receiving placebo (30 deaths of 53 patients) and 33% for patients receiving platelet-activating factor receptor antagonist (22 deaths of 67 patients; p = .01). "
06/01/1996 - "Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis."
01/01/2003 - "To directly assess the impact of platelet-activating factor on the development of colitis, we also determined the efficacy of a specific platelet-activating factor receptor antagonist for preventing dextran sulfate sodium-induced colitis. "
01/01/2003 - "The platelet-activating factor receptor antagonist effectively ameliorated colitis, along with causing a decrease in the tissue cytokine-induced neutrophil chemoattractant messenger ribonucleic acid level and a decline in neutrophil and macrophage infiltration. "
03/01/2012 - "This suggests that the platelet activating factor receptor (PAFR) acts to suppress chronic inflammation in response to other stimuli, such as barrier disruption. "
03/01/2012 - "Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis."
01/01/1999 - "We hypothesized that the activation of PAF receptors is central to the development of inflammation and epithelial injury induced by acute O3 exposure in mice. "
08/01/2014 - "Platelet-activating factor receptor (PAFR) plays an important role in bacterial infection and inflammation. "
04/01/2014 - "Activation of platelet-activating factor receptor exacerbates renal inflammation and promotes fibrosis."
12/01/2010 - "Prolonged hypoxia modulates platelet activating factor receptor-mediated responses by fetal ovine pulmonary vascular smooth muscle cells."
02/15/2010 - "A screen of relevant pathway inhibitors identified a prominent role for the platelet-activating factor receptor (PAFr) in hypoxia-associated bacterial translocation, wherein pharmacologic antagonists of PAFr blocked bacterial translocation by as much as 80 +/- 6%. "
02/15/2010 - "Hypoxia-inducible factor-dependent regulation of platelet-activating factor receptor as a route for gram-positive bacterial translocation across epithelia."
08/01/2004 - "Platelet-activating factor receptor modulates respiratory adaptation to long-term intermittent hypoxia in mice."
06/01/1997 - "These data suggest that hypoxia releases PAF or an endogenous lipid PAF inhibitor that desensitizes PAF receptors on colonic epithelial or mucosal cells. "
02/15/2004 - "Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice."
02/01/2014 - "Prevotella intermedia induces severe bacteremic pneumococcal pneumonia in mice with upregulated platelet-activating factor receptor expression."
01/01/2006 - "pneumoniae utilizes the platelet-activating factor receptor (PAFR) to invade the respiratory epithelium and that the PAFR is upregulated during viral infection, we here used PAFR gene-deficient (PAFR-/-) mice to determine the role of this receptor during postinfluenza pneumococcal pneumonia. "
06/05/2012 - "CCAAT/enhancer-binding protein δ facilitates bacterial dissemination during pneumococcal pneumonia in a platelet-activating factor receptor-dependent manner."
|1.||Platelet Activating Factor
|5.||Histamine (Histamine Dihydrochloride)
|6.||1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)
|1.||Drug Therapy (Chemotherapy)